13. June 2022
Recruitment to the REMED study on COVID-19 in serious condition was terminated on March 9, 2022 due to a receding pandemic. The sponsor of this clinical trial is the University Hospital Brno and is implemented in cooperation with the CZECRIN research infrastructure. 8 centers across the Czech Republic are actively involved in the study, which included a total of 235 patients out of 300 planned. A statistical evaluation of the primary objective and the preparation of a publication are currently underway. Enrolled patients will be followed up in the study according to the approved protocol.